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Abstract
Objective. To perform a comprehensive review of the litera-
ture from July 2011 until June 2015 on the virology and bac-
teriology of otitis media in children.
Data Sources. PubMed database of the National Library of
Medicine.
Review Methods. Two subpanels comprising experts in the vir-
ology and bacteriology of otitis media were created. Each
panel reviewed the relevant literature in the fields of virology
and bacteriology and generated draft reviews. These initial
reviews were distributed to all panel members prior to meet-
ing together at the Post-symposium Research Conference of
the 18th International Symposium on Recent Advances in
Otitis Media, National Harbor, Maryland, in June 2015. A final
draft was created, circulated, and approved by all panel
members.
Conclusions. Excellent progress has been made in the past 4
years in advancing our understanding of the microbiology of
otitis media. Numerous advances were made in basic labora-
tory studies, in animal models of otitis media, in better under-
standing the epidemiology of disease, and in clinical practice.
Implications for Practice. (1) Many viruses cause acute otitis
media without bacterial coinfection, and such cases do not
require antibiotic treatment. (2) When respiratory syncytial
virus, metapneumovirus, and influenza virus peak in the
community, practitioners can expect to see an increase in
clinical otitis media cases. (3) Biomarkers that predict which
children with upper respiratory tract infections will develop
otitis media may be available in the future. (4) Compounds
that target newly identified bacterial virulence determinants
may be available as future treatment options for children
with otitis media.
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Introduction
Otitis media (OM) is caused by viral and/or bacterial infec-
tion of the middle ear (ME) space and the resulting host
response to infection. Important new work has been pub-
lished in the areas of microbial pathogenesis, molecular epi-
demiology, genomics, new viruses, and polymicrobial
interactions. This report provides an overview of important
recent research in these areas.
Methods
The panel reviewed PubMed to identify important articles
related to the microbiology of OM published between July
2011 and June 2015. Keywords included otitis media and
Streptococcus pneumoniae (Spn), nontypeable Haemophilus
influenzae (NTHi), or Moraxella catarrhalis (Mcat) or indi-
vidual respiratory viruses. Members drafted initial reports
summarizing advances in their areas of expertise before a
composite draft document was circulated to all panel
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members prior to the conference. The panel met at the con-
ference, where the draft was reviewed, additional articles
added, and research goals proposed. A final draft was circu-
lated to all panel members for approval following the
conference.
Discussion
Virology
Experimental animal/in vitro models. Short et al developed an
infant mouse model to study influenza A virus (IAV)- and
Spn-induced OM.1 Compared with single challenge, coin-
fection was associated with greater bacterial burden, inflam-
matory cell influx into the ME, and concordant hearing loss.
IAV-induced inflammation contributed to Spn transmission
among cohoused naive and Spn-colonized mice.2 H3N2
hemagglutinin facilitated Spn-induced OM via activation of
proinflammatory mediators.3 Binding of hemagglutinin to
host a2,6-linked sialic acid was negated as a factor
promoting viral replication in the ME or secondary bacterial
OM.4 Wren et al5 showed that transparent colony pheno-
types of Spn were more adherent than opaque in vitro and
that IAV-induced inflammation abrogates this defect in
vivo.
It was reported that live attenuated influenza vaccine
(LAIV) promotes Spn colonization.6 Mina and coworkers7
used a murine model to show greater incidence and duration
of Spn-induced ME disease after live attenuated influenza
vaccine inoculation. Tong et al8 demonstrated that C1qa and
factor B deficiencies yielded greater bacterial and viral bur-
dens in IAV and Spn coinfected mice and that lacking C5a
receptor resulted in fewer Spn in the ME regardless of IAV
infection.
McGillivary et al9 identified viperin as a respiratory tract
antiviral protein in chinchillas. Transduction of adeno-
associated virus encoding viperin into the nasopharynx of
chinchillas who were then challenged with respiratory syn-
cytial virus (RSV) limited RSV titers. Murrah et al10
showed that prior infection with adenovirus type 5 resulted
in greater proportion of Spn-infected ME compared with no
virus in the chinchilla. Brockson et al11 developed a chinch-
illa model of Mcat-induced OM whereby sequential intrana-
sal inoculation of NTHi, Mcat, and RSV resulted in culture-
positive ME for 11 days.
Epidemiologic, clinical, and viral diagnostics. Peak activity of
RSV, metapneumovirus, and influenza A coincided with
pediatric office visits for acute OM (AOM).12 In children
with history of recurrent OM undergoing ventilation tube
insertion,13 71% of ME fluids (MEFs) contained viruses,
mostly rhinovirus. In children with acute otorrhea, viruses
were detected in 58% of nasopharyngeal samples and 21%
of otorrhea samples.14 In a longitudinal study,15 viruses
were detected in 76% of upper respiratory tract infection
(URI) specimens and 27% of asymptomatic specimens.
Asymptomatic viral infections were not complicated by
AOM. Viral load was higher in URI specimens than in
asymptomatic specimens but did not differentiate URI with
and without AOM complication.
The clinical relevance of samples positive for rhinovirus
RNA was determined by pyrosequencing 179 rhinovirus
strains from successive nasopharyngeal specimens from
infants.16 Prolonged presence of rhinovirus .30 days occurred
in only 4.5%, suggesting that detection of rhinovirus RNA
most likely represents an infection within 30 days.
The clinical spectrum of AOM complicating URI was
described in 294 children.17 During days 1 to 7 of URI
onset, AOM was documented in 22%. AOM presented at
various stages from mild to severe, with perforation.
Ede et al18 studied lactate dehydrogenase concentrations in
nasopharyngeal secretions from children with URI. High lac-
tate dehydrogenase concentrations were associated with AOM,
especially during the first 4 days of URI, and with adenovirus,
bocavirus, and rhinovirus infections. Christensen et al reported
no correlation between AOM severity and C-reactive protein,
peripheral blood white blood cell count, or the absolute neutro-
phil count.19
Role of specific viruses. In hospitalized children in Greece,
AOM was diagnosed in higher proportions of children with
seasonal influenza A than in those with 2009 H1N1 pandemic
influenza A,20 suggesting the lower ability of pandemic virus
to induce AOM. In Texas, infants were followed for URI and
AOM through a 31-month period before, during, and after the
influenza A pandemic.21 The pandemic virus did not increase
the prevalence of URI or AOM but did increase parents’
awareness and resulted in more parent-initiated health care
visits for respiratory infections.
In Croatia, AOM was diagnosed in 28% of hospitalized
children with adenovirus.22 In Finland, parechovirus was
found in 12% of 100 children with AOM23; in 4 (33%) chil-
dren, parechovirus was detected in the MEF with no
bacteria.
Primary human bocavirus 1 (HBoV1) infection was associ-
ated with symptomatic URI and AOM by serology.24 Many
studies reported human bocavirus (HBoV) detection in the naso-
pharynx and/or MEF of children with OM.25-28 In Taiwan,25
HBoV was detected in throat swabs from 35 of 705 children
with acute respiratory infection, 3 of whom had AOM. In a
study of 707 nasopharyngeal samples from 201 children with
URI, HBoV1 was detected in 24% and was the only virus in
6%.28 HBoV1 appeared to be ototropic; 52% of children with
URI and HBoV1 had only AOM. In 2 prospective studies,
HBoV1 could be detected repeatedly from the nasopharyngeal
samples even 3 months apart.26,28 Because HBoV may have a
prolonged presence in the nasopharynx, the clinical significance
of HBoV positivity during URI and AOM is still debatable. In
children with URI, HBoV1 viral load was not associated with
presence of AOM.26
In a prospective study, 7% of URI episodes were positive
for human metapneumovirus (HMPV).29 In 3.6% of URI
episodes, HMPV was the only virus; of these, 24% were
complicated by AOM. HMPV viral load was not associated
with AOM.
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Polyomavirus was detected in MEFs of children with a
history of recurrent OM who underwent ventilation tube
insertion.13 Enterovirus C118 was detected in 2 children
with AOM and community-acquired pneumonia.30
Viral-bacterial interactions. Van den Bergh et al described dis-
tinct bacterial-bacterial, viral-bacterial, and viral-viral asso-
ciations in 986 nasopharyngeal samples from asymptomatic
children.31 Pettigrew et al reported increased AOM risk
with high RSV viral load plus Spn or NTHi and with boca-
virus and NTHi.32 Ruohola et al studied nasopharyngeal
samples from children with URI/AOM.33 RSV, without
presence of bacteria, was associated with AOM risk. In
Australian indigenous children, bacterial loads were higher
in children with AOM compared with children without.34
Children infected with adenovirus were 3 times more likely
to have AOM.
In 10 adult volunteers inoculated with rhinovirus, each had
a unique bacterial profile; bacterial load did not change during
rhinovirus infection.35 Based on 16SrRNA sequencing, the
most abundant genus in the nasopharyngeal samples was
Alloiococcus, followed by Corynebacterium, Staphylococcus,
Haemophilus, Propionibacterium, and Streptococcus.36 There
was greater diversity of bacterial flora in rhinovirus infected
compared with uninfected subjects. Neisseria and Propioni-
bacterium genera differed significantly between these groups.
In South African children with human immunodeficiency virus
infection, spectrum of viral URI and bacterial OM were simi-
lar to those in uninfected children.37
Bacteria: Nontypeable Haemophilus influenzae
Pathogenesis. Hallstrom and coworkers reported the laminin-
binding region of protein E was localized to the N-terminus
and protein E bound to the heparin-binding C-terminal glob-
ular domain of laminin.38 Lee and coworkers identified sig-
naling pathways critical to development of ME granulation
tissue.39 TGF-b was upregulated in MEs with OM. TGF-b
pathway products were higher in NTHi-infected ears than in
pneumococci-infected ears. Oh and coworkers studied inner
ear inflammation40 and found that inner ear spiral ligament
fibrocytes released CXCL2 in response to NTHi via c-Jun
activation, leading to recruitment of polymorphonuclear
cells to the cochlea, and that MEK1/ERK2 signaling is
required for NTHi-induced CXCL2 upregulation. Preciado
and colleagues examined signaling pathways involved with
ME metaplasia following transtympanic inoculation of
Balb/c mice with NTHi lysates.41 Microarrays showed that
CXCL2 had the largest fold change, with increased expres-
sion at 1 and 7 days after NTHi injection.
Harrison and colleagues examined the contribution of Fur
in acquisition of iron.42 Most genes encoding proteins with
roles in iron utilization were repressed by Fur. In the chinch-
illa, Fur was critical for bacterial persistence. Whitby and col-
leagues described transcription profiles of iron-related genes in
vitro and in vivo.43 The core of iron- and heme-responsive
genes consisted of 35 genes maximally expressed under heme
restriction and 20 more maximally expressed in heme-replete
conditions. Most core modulon members were upregulated in
the chinchilla ME during OM.
Harrison and coworkers studied genetic loci important in
the stress response.44 A catalase hktE mutant and a peroxire-
doxin/glutaredoxin pgdX hktE double mutant were more
sensitive than the parent to H2O2 killing. The pgdX mutant
was more resistant to H2O2 due to increased catalase activ-
ity. Binding of iron by Dps mitigated the effect of H2O2-
mediated killing. An isogenic strain lacking hktE and pdgX
had increased susceptibility to peroxide.45 These strains had
persistence defects in chinchilla OM and in a murine model
of chronic obstructive pulmonary disease (COPD).
Raffel and coworkers explored the contribution of Sap to
NTHi interaction with the host epithelium.46 SapA-deficient
NTHi demonstrated increased invasion compared with the
parent strain. Upon internalization, the sapA mutants appeared
free in the cytoplasm, whereas the parent strain was found in
endosomes, indicating differential subcellular trafficking.
Reduced inflammatory cytokines were produced by the epithe-
lium in the sapA mutant, and chinchilla MEs challenged with
the sapA mutant showed decreased disease severity.
Biology of NTHi, biofilms. Pang and coworkers examined the
contribution of Dps to NTHi survival in biofilms.47 A dps
mutant had a survival defect in high-iron conditions, which
was mediated by oxidative stress and restored by genetic
complementation. No differences were observed in density
and structure of biofilms produced by the parent and dps
mutant, but survival was decreased in mutant biofilms.
Mutant survival was less in chinchilla OM and the mouse
pulmonary clearance model.
Jones and coworkers examined the contribution of extra-
cellular DNA (eDNA) to biofilms.48 Recombinant hBD-3,
or (r)hBD-3, bound eDNA in vitro, and eDNA in biofilms
in the chinchilla ME colocalized with the chinchilla hBD-3
equivalent. Incubation of (r)hBD-3 with NTHi genomic
DNA prevented (r)hBD-3 from inhibiting NTHi biofilm for-
mation in vitro. Establishment of NTHi biofilms in the pres-
ence of DNase I and (r)hBD-3 caused a reduction in biofilm
height and thickness and rescued the antimicrobial activity
of the AMP.
Puig and coworkers studied NTHi from patients with
nonbacteremic community-acquired pneumonia, COPD,
OM, and invasive disease and from healthy colonized chil-
dren for ability to form biofilms.49 Increased biofilm forma-
tion was observed for NTHi from patients with invasive
disease and OM as compared with NTHi from other
patients. Isolates from the oropharynx and MEF had more
phosphorylcholine and made denser biofilms than isolates
from sputum of patients with COPD or nonbacteremic
community-acquired pneumonia. No correlation was found
between biofilm formation and the presence of phosphoryl-
choline in lipooligosaccharide (LOS).
Cho and coworkers examined the role of nuclease.50
They demonstrated biofilm dispersal in the parent strain, no
dispersal in a nuclease mutant, and partial dispersal in a
complemented mutant. Microscopic analysis of biofilms
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showed increased nucleic acid matrix in the nuclease
mutant. The nuclease mutant formed a biofilm in chinchilla
OM and demonstrated a propensity to form large aggregates
of organisms.
Genetics and genomic studies of NTHi. Using multilocus
sequence typing, LaCross and coworkers identified 109
sequence types among 170 commensal and OM-associated
isolates from Finland, Israel, and the United States.51 The
largest clonal complex contained 5 sequence types. Little
clustering was apparent by disease state or geography.
Population structure was evident, with support for 8 popula-
tions when all isolates were analyzed.
Zhang and colleagues found the urease operon more pre-
valent in NTHi causing OM and COPD-associated bronchi-
tis than NTHi from throats of healthy individuals.52 Strains
lacking the operon were much more likely to be from the
throat than from OM or COPD isolates.
LaCross and coworkers found 47 hemin receptor (HemR)
amino acid sequences among 146 isolates.53 The predicted
structure of HemR was similar to TonB-dependent, ligand-gated
channels involved in iron acquisition in other bacteria. Fifteen
amino acid polymorphisms were more prevalent among com-
mensal than otitis isolates. After controlling for population struc-
ture, only 7 polymorphisms retained significance.
Hariadi and coworkers compared the heme acquisition
gene profiles of disease-causing and colonizing NTHi and
Haemophilus haemolyticus.54 Four of 5 heme acquisition
genes (hxuA, hxuB, hxuC, and hemR) were more prevalent
in ME compared with throat strains. All 5 genes were more
prevalent in NTHi than in H haemolyticus.
Interactions with the host immune system. Langereis and col-
leagues reported increased complement resistance in NTHi
from the ME, correlating with decreased binding of IgM.55
NTHi gene R2866_0112 had a role in complement resis-
tance: gene deletion altered the LOS and increased IgM
binding and complement-mediated lysis. In a mouse model,
the R2866_0112 mutant was less virulent. The group also
reported that NTHi prevented complement-dependent
neutrophil-mediated killing: expression of surface oligo-
saccharides blocked recognition of a critical LOS epitope
by replacement with galactose attached to HepIII or
through shielding HepIII-b 1,2-Glc by attachment of oli-
gosaccharide chain extensions.56
Wang and coworkers examined the role of deubiquitinase
cylindromatosis (CYLD) in NTHi-induced inflammation.57
They reported that in human lung A549 cells and lungs of
Cyld–/– mice, CYLD targets the activation of ERK. CYLD
also enhanced NTHi-induced upregulation of MAP kinase
phosphatase-1, which led to reduced ERK activation and
subsequent suppression of IL-8.
Woo and coworkers demonstrated that human ME
epithelial cells upregulated DEFB4 (human b-defensin 2) in
response to NTHi via NF-kB activation.58 Deletion of the
distal NF-kB binding motif caused reduction in NTHi-
induced DEFB4 upregulation. Internalized NTHi existed
free in the cytoplasm of epithelial cells after rupturing the
surrounding membrane.59 Human ME epithelial cells inhib-
ited NTHi-induced b-defensin 2 production by NOD2 silen-
cing but augmented it by NOD2 overexpression. NOD2
deficiency reduced inflammatory reactions following intra-
tympanic injection of NTHi and inhibited NTHi clearance
from the ME.
Woo and coworkers studied cochlear inflammation in
NTHi OM60 and found that IL-10 receptors were expressed
in lateral wall spiral ligament fibrocytes. Rat spiral ligament
fibrocyte cells inhibited NTHi-induced upregulation of
MCP-1 (monocyte chemotactic protein 1) in response to IL-
10. Inhibition was suppressed by silencing IL-10R1 and was
mimicked by cobalt protoporphyrin IX and CO-releasing
molecule 2. IL-10 suppressed monocyte recruitment through
reduction of spiral ligament fibrocyte chemoattractants. IL-
10 inhibited NTHi-induced binding of p65 NF-kB to the
distal motif in the promoter region of MCP-1/CCL2, result-
ing in suppression of NF-kB activation.
Streptococcus pneumoniae
Genomics. High-throughput sequencing projects continue to
inform our understanding of Spn pathogenesis.61 Small non-
coding RNAs were identified in Spn through RNA sequencing.
Targeted deletions and transposon mutagenesis demonstrated
that specific small noncoding RNAs were required for tissue-
specific virulence.62 The genome sequence of a multidrug-
resistant serotype 19F OM isolate was recently published63
and will complement pathogenesis studies.64 A whole genome
sequencing study of 616 Spn isolates examined the impact of
PCV-7 on S pneumoniae. Rates of recombination differed
across lineages, and pneumococcal strains appear to evolve by
mutation at a consensus rate of 1.0 3 1026 to 1.5 3 1026
mutations per base per year. Capsule switches occurred
between related lineages, and most preceded introduction of
conjugate vaccines. These data indicate that common post-
PCV lineages arose by replacement of vaccine serotypes by
nonvaccine serotypes that were rare prior to introduction of
conjugate vaccines.65 A whole genome sequencing study of
3085 Spn isolates from children identified hotspots for recom-
bination that included genes encoding antibiotic resistance and
the PspA and PspC surface antigens.66
Mechanisms of Pathogenesis
Biofilms. A proteomic study showed that biofilm bacteria
utilize alternative metabolic pathways and downregulate
capsule and other virulence factors as compared with
planktonic pneumococci.67 Biofilm pneumococci show an
avirulent phenotype and are unable to cause AOM in some
animal model systems.68-70 Marks and coworkers recently
showed that changes in the nasopharyngeal environment
(including influenza A virus infection) and resulting host
changes (including increased temperature, release of ATP
and norepinephrine) caused dispersion of nasopharyngeal
biofilm bacteria and that the dispersed bacteria ascended
the eustachian tube and caused AOM.70 Dispersed bacteria
exhibit different transcriptional profiles than biofilm
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bacteria71; virulence factors—including capsule, pspA, ply,
pcpA, nanA, nanB, and bacteriocins—were upregulated,
whereas competence genes and adhesins were downregu-
lated. A shift from purine/pyrimidine and amino acid meta-
bolism to carbohydrate metabolism occurred.71
In rodent models, Mcat was found to increase ascension
of pneumococci into the ME, and pneumococci increased
the bacterial burden of Mcat. Additionally, Mcat conferred
passive protection against b-lactam killing of pneumococci
in dual biofilms.72
Biofilm formation and horizontal gene transfer. Recent studies
have implicated host GalNAc as a receptor important for
biofilm formation73 and a number of virulence factors,
including Ply, CpbA/PspC, and PhpP in biofilm forma-
tion.74-76 Quorum sensing through the LuxS/AI-2 system
and competence is required for optimal biofilm forma-
tion.77-79 Additionally, interaction with epithelial cells
improves biofilm formation in vitro.76,80,81 A major portion
of pneumococcal biofilm matrix comes from cells lysed by
the major autolysin LytA or through fratricide.81,82 The
matrix consists of cellular debris, including DNA and DNA-
protein complexes in which LytC appears to be a major
component.83 DNA in the matrix makes the biofilm envi-
ronment optimal for genetic exchange of fitness and antibio-
tic resistance genes.82,84
Biofilm treatment. Lysins effectively disrupt pneumococcal
in vitro biofilms.85,86 The quorum-sensing inhibitor yd47
prevents biofilm formation in vitro and OM in a guinea pig
model.87 Macrolides and fluoroquinolones are the most
effective antibiotics for disrupting biofilms in vitro.88 The
sensitizing milk protein HAMLET increases the potency of
antibiotics to both sensitive and resistant pneumococcal
strains.89
Complement. Phosphoglycerate kinase and elongation factor
Tu were shown to be pneumococcal complement regulatory
proteins.90,91 Phosphoglycerate kinase inhibits assembly of
the membrane attack complex, and elongation factor Tu
binds factor H. In a mouse model of OM, investigators
tested the complement-mediated killing of transparent and
opaque colony forms.92 More complement was deposited on
the transparent phenotype and was dependent on the alterna-
tive pathway. Capsule switching from 6A to 6C was accom-
panied by a reduction in complement C3 deposition from
the donor strain associated with increased virulence in an
OM model in the chinchilla.93 Children with OM were
shown to upregulate genes associated with the classical and
alternative pathways in peripheral blood monocytes.94
Capsule. Regulation of capsule is critical for pneumococ-
cal pathogenesis.95 A mutation in the gene encoding the
arginine transporter ArcD caused a reduction in capsule pro-
duction and ability to cause OM in a chinchilla model,
likely due to differences in the surface association of cap-
sule.96 A study demonstrated that a laboratory-generated
capsular switch led to increased pathogenesis in a chinchilla
barotrauma model of AOM.93 In another barotrauma model
of OM, serotype 6C strains showed reduced ability to pro-
duce ME disease as compared with serotype 19A isolates.97
This correlates with the increased ability of 19A isolates to
cause AOM and may relate to differences in levels of com-
plement binding.97,98
Up to 16% of Spn carriage isolates do not encode cap-
sule66 and strains lacking capsule have been isolated from
OM and can cause OM in chinchillas.99 Nonencapsulated
Spn, distinct from those to which capsule cannot be assigned,
are divided into those that contain a capsule locus but are
defective in production and those that lack the locus. This
second group is divided into 3 null capsule clades (NCCs):
pspK positive (NCC1), pspK negative but with aliC and aliD
in place of the capsule locus (NCC2), and strains with aliD
but not aliC (NCC3).100,101 PspK binds secretory IgA,
increases adherence to epithelial cells, and enhances coloni-
zation in a mouse model.101,102 All 8 pspK1 isolates tested
and half of naturally pspK-negative nontypeable isolates
caused AOM following transbullar inoculation.103 When
pspK was deleted, reduced bacterial burden and decreased
pathology were observed. Introduction of pspK into the unen-
capsulated strain R36A enabled this avirulent strain to cause
AOM.103 Classic nonencapsulated lineages may play a role
in pneumococcal OM as sources of antibiotic resistance
genes.66,104
Glycosidases. Glycosidases provide pneumococci with
carbohydrates—for example, hyaluronic acid can be degraded
and used as a carbon source.105 Pneumococcal b-galactosidase
BgaA binds to host cell surface galactose b,1-4–linked carbo-
hydrates following sialic acid removal by NanA and may rep-
resent a new family of adhesins.106,107 Increased GalNAc
residues are present along the eustachian tube and in submuco-
sal serous glands during infection and may serve as receptors
for adherence.73,108
Mucin production can be synergistically increased in the
presence of pneumococci and NTHi.109-111 How pneumo-
cocci reach the epithelial cell surface through the mucins is
unclear. Production of a truncated and secreted zinc metal-
loproteinase by some strains allows cleavage of MUC16
from epithelial cells, penetration of the glycocalyx, and
increased adherence.112,113
Additional pathogenesis papers. Cyclic-di-AMP regulates
complex cellular processes that can be degraded by phos-
phodiesterases.114 Cron et al identified 2 pneumococcal
cyclic-di-AMP phosphodiesterases (Pde1 and Pde2) that
contribute to OM in a murine model.115,116 Single mutants
in PspA, CbpA, and pneumolysin were significantly reduced
in bacterial counts in the chinchilla OM model, although the
CbpA mutant was only mildly attenuated.117,118 A double
PspA/CbpA mutant was reduced in pathogenicity similar to
the PspA mutant, but a PspA/pneumolysin double mutant
showed no reduction in pathogenicity.
Polymicrobial interactions. Profiling studies in children based
on 16S rRNA highlight the association among the respira-
tory microbiota, Spn colonization, and OM susceptibility.119-
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121 Taxa, including Staphylococcus, have been negatively asso-
ciated with colonization by Spn.120Corynebacterium and
Dolosigranulum have been shown to be protective for develop-
ment of OM.121Actinomyces, Rothia, Neisseria, and Veillonella
were associated with increased odds of AOM.121
Moraxella catarrhalis
Genomics of Mcat. Davie and colleagues compared 12 geno-
mic sequences122 and observed a surprising degree of gene
conservation; in addition to conserved core genes, a set of
.600 unevenly distributed gene clusters was observed, and
there was a low rate of mobile genetic elements.123 A geno-
mic sequence was released for Mcat BBH18, an isolate
from a COPD patient,124,125 and it had 10 unique open read-
ing frames (ORFs), including 8 in a contiguous region of
the genome.
Epigenetic variation. Phase-variable DNA methyltransferases
(modM) were described in Mcat, and differential methyla-
tion was demonstrated in accordance with phase status of
mutant strains.126 Analysis Mcat isolates from carriage and
disease revealed 3 modM alleles (modM1, modM2, and
modM3); modM3 was disproportionately represented in the
OM isolates.
Transcript profiling. Hansen’s group constructed a microarray
based on Mcat ATCC 43617 to perform transcript profiling.
Hoopman et al studied exposure to oxidant and observed
increased expression for oxyR, catalase (katA), and peroxi-
dase (ahpCF), with results validated by real-time polymer-
ase chain reaction and confirmation of oxidant sensitivity
phenotypes for isogenic mutants.127
The same group used microarrays to study colonization
of the chinchilla nasopharynx.128 Growth in vivo demon-
strated .100 gene products with increased expression and
.200 with decreased expression: increased expression for
at least 5 regulatory genes and increased expression of
nitrate/nitrite metabolism genes, most notably aniA, with
the latter suggesting that the Mcat population is in a biofilm.
Several surface factors associated with adherence (hag,
mcaP, and mchA1) were decreased in the colonizing popu-
lation. An Mcat isogenic mutant was generated in MC ORF
1550 that was shown to confer a fitness defect in chinchilla
nasopharyngeal infections.
Identification of essential genes. Mobegi et al generated a
transposon mutant library in Mcat BBH18 analyzed by deep
sequence analysis to identify ORFs not represented in the
viable transposon mutant pools.129 In sum, 445 potentially
essential genes were identified with functions including bio-
synthesis of fatty acids, vitamins, and isoprenoids. Lead
compounds targeting these pathways were shown to have
efficacy against Mcat, and other OM pathogens.
Metabolism and growth. Genes required for survival of Mcat
in iron-limiting conditions were identified by a transposon
library screen using Tn-seq.130 Five ORFs were identified in
1 Mcat strain as necessary for survival in low-iron
conditions. Validation in additional Mcat strains revealed
that the most significant among multiple strains was yggW,
predicted to function in heme acquisition.
Spaniol and colleagues performed transcriptome analyses
to find genes with increased expression in low tempera-
ture.131 They observed increased expression of several
genes indicating membrane remodeling: an efflux pump, a
porin, and other outer membrane proteins. The most notable
finding concerned expression of the type IV pilus,132 which
was also increased. This was phenotypically verified as the
efficiency of DNA uptake, and transformation was increased
at the lower temperature.
Mechanisms of pathogenesis. Using Tn-seq, de Vries and col-
leagues identified 15 genes that were important to colonization
of immortalized epithelial cells,133 including a glycosyltrans-
ferase (lgt1) involved in LOS biosynthesis,134,135 a putative
lipoprotein and an outer membrane protein, entericidin
(ecnAB), and a regulator with homology to the BadM family.
Adherence phenotypes were confirmed with isogenic mutant
strains.
Hansen and colleagues used microarray to identify tran-
scripts with increased levels during colonization of immor-
talized 16HBE14 human bronchial epithelial cells.136 They
identified a lipoprotein (ORF113) with increased expression
shown to affect persistence of Mcat within the chinchilla
nasopharynx.
Buskirk and Lafontaine showed that synthesis of cardiolipin
was a determinant of survival of Mcat O35E on immortalized
epithelial cells, as an isogenic mclS strain lacking cardiolipin
had lower recovery from cell infection studies.137
Lgt3 is a LOS glucosyltransferase that has been shown to
mediate addition of b-(1,4) Glc moieties to the inner core of
the LOS.134 Recently, the function of Lgt3 was shown to be
more complex and to include separate transferase domains
that mediate addition, respectively of b-(1,3) Glc (domain
1) and b-(1,4) Glc and b-(1,6) Glc (domain 2).138
Implications for Clinical Practice and
Research Goals
The advances of the past 4 years have several implications
for clinical practice (Table 1). They also form the basis for
the panel’s proposed research goals for the microbiology of
OM:
1. The role of inflammatory mediators and their
mechanisms of action in AOM pathogenesis fol-
lowing viral URI should be studied.
2. The impact of viral and bacterial load in the naso-
pharynx on generation of local inflammation,
AOM development, disease severity, and outcome
should be studied.
3. The significance of newly detected viruses, multi-
ple virus infection, and persistent viral infection
should be examined.
4. Extend animal models of OM to include common
URI viruses, such as rhinovirus.
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5. Evaluate whether specific viruses interact with
specific bacteria and elucidate mechanisms of
viral-bacterial interaction on the mucosal level.
6. Understand how OM pathogens interact with one
another and with commensals in the nasopharynx
and ME.
7. Prevention of AOM by prevention and/or early
treatment of viral URI should be studied.
8. Understand host genetics in URI susceptibility
and AOM development following URI.
9. Additional studies to longitudinally examine the
microbiota in the nasopharynx and ME.
10. Exploit advances in bacterial genomics to understand
mechanisms of pathogenesis, molecular epidemiol-
ogy, and emerging antimicrobial resistance patterns.
11. Develop therapeutics effective against biofilms by
further studying their role in pathogenesis.
12. Understand how OM pathogens interact with one
another and with commensals in the nasopharynx
and ME.
13. Better understand the pathogenesis of nontypeable
Spn OM.
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